Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 02, 2022		Oct. 03, 2021
Cash flows from operating activities:
Net income (loss)	$ 51,845		$ (59,036)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	25,096		7,498
Stock-based compensation	19,056		19,776
Non-cash interest expense	2,556		4,095
Equity in (earnings) losses of unconsolidated investees	(1,958)		0
(Gain) loss on equity investments	(120,965)		47,238
(Gain) loss on sale of investments	0		(1,162)
(Gain) loss on business divestitures, net	0		(224)
Unrealized (gain) loss on derivatives	(2,304)		0
Dividend from equity method investees	133		0
Deferred income taxes	(12,606)		(4,109)
Other, net	128		(6,335)
Changes in operating assets and liabilities:
Accounts receivable	(66,254)		(4,450)
Contract assets	2,326		28,687
Inventories	(22,787)		(3,758)
Project assets	295		2,817
Prepaid expenses and other assets	(212,164)		(10,915)
Operating lease right-of-use assets	8,424		8,709
Advances to suppliers	(6,288)		(687)
Accounts payable and other accrued liabilities	77,844		(56,245)
Contract liabilities	98,663		(3,507)
Operating lease liabilities	(10,906)		(10,457)
Net cash used in operating activities	(169,866)		(42,065)
Cash flows from investing activities:
Purchases of property, plant, and equipment	(36,958)		(3,934)
Investment in software development costs	(4,225)		(2,468)
Proceeds from sale of property, plant, and equipment	0		900
Cash paid for solar power systems	0		(635)
Cash received from sale of investments	0		1,200
Proceeds from business divestitures, net of de-consolidated cash	0		10,516
Cash received from C&I Solutions sale, net of de-consolidated cash	146,303		0
Cash paid for equity investments	(30,920)		0
Proceeds from sale of equity investment	440,108		177,780
Proceeds from return of capital from equity investments	0		2,276
Cash paid for investments in unconsolidated investees	(5,742)		0
Dividend from equity method investee	137		0
Net cash provided by investing activities	508,703		185,635
Cash flows from financing activities:
Proceeds from bank loans and other debt	124,729		123,669
Repayment of bank loans and other debt	(167,003)		(156,386)
Repayment of non-recourse residential and commercial financing debt	0		(9,798)
Repayment of convertible debt	0		(62,757)
Payments for financing leases	(735)		0
Issuance of common stock to executive	0		2,998
Purchases of stock for tax withholding obligations on vested restricted stock	(10,462)		(7,262)
Net cash used in financing activities	(53,471)		(109,536)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	0		0
Net increase (decrease) in cash, cash equivalents, and restricted cash	285,366		34,034
Cash, cash equivalents, and restricted cash, beginning of period	148,613		246,804
Cash, cash equivalents, and restricted cash, end of period	433,979		280,838
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets, including discontinued operations:
Cash and cash equivalents	396,510		268,574
Restricted cash and cash equivalents, current portion	13,204	[1]	7,438
Restricted cash and cash equivalents, net of current portion	24,265	[1]	4,826
Total cash, cash equivalents, and restricted cash	433,979		280,838
Supplemental disclosure of cash flow information:
Property, plant and equipment acquisitions funded by liabilities (including financing leases)	9,130		2,530
Right-of-use assets obtained in exchange for lease obligations	14,005		15,957
Working capital adjustment related to C&I Solutions sale	7,005		0
Accrued legal expenditures on equity method investment	168		0
Accrued debt issuance costs	919		0
Deconsolidation of right-of-use assets and lease obligations	0		3,340
Debt repaid in sale of commercial projects	0		5,585
Cash paid for interest	20,323		23,734
Cash paid for income taxes	$ 5,187		$ 20,316

[1] Amounts included in the “Restricted cash and cash equivalents, current portion” and “Restricted cash and cash equivalents, net of current portion” financial statement line items on our condensed consolidated balance sheets include cash balances set aside for various financial obligations including loans, distributions, letter of credit facilities, and other projects’ related cash transactions